Silence Therapeutics's total assets for Q4 2022 were £107.50M, a decrease of -13.33% from the previous quarter. SLN total liabilities were £85.43M for the fiscal quarter, a -4.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.